Novartis AG (BSP:N1VS34)
R$ 61.14 -3.4 (-5.27%) Market Cap: 1.22 Tn Enterprise Value: 1.32 Tn PE Ratio: 12.54 PB Ratio: 5.07 GF Score: 77/100

Novartis AG Annual Shareholders Meeting Transcript

Mar 04, 2022 / 01:00PM GMT
Release Date Price: R$42 (-3.38%)
Joerg Reinhardt
Novartis International AG - Chairman of the Board of Directors

[Interpreted] Distinguished shareholders, ladies and gentlemen, I would like to welcome you very cordially to the 26th Ordinary Annual General Meeting of Novartis AG.

Before I start dealing with the agenda of today's AGM, I wish to first comment on the war and the dramatic development in the Ukraine. We condemn the invasion of the Ukraine by Russian troops as well as the use of any force as a means to solving a conflict. Our thoughts are with the people in the war zone and our 500 employees in the Ukraine as well as with our colleagues in the entire region who are doing whatever they can to support our colleagues in the Ukraine.

We are observing this development very closely, and we are already working hard on developing emergency plans to be able to continue providing drugs and therapies to patients in need. Furthermore, we have decided to donate $3 million to provide immediate emergency aid.

It is still too early to exactly assess the economic repercussions of the Russian invasion of the Ukraine.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot